Real-world effectiveness of azvudine for patients infected with the SARS-CoV-2 omicron subvariant BA.5 in an intensive care unit

BACKGROUND: Azvudine (FNC) has been shown to be effective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but data regarding the Omicron BA.5.1.3 subvariant are lacking. This retrospective analysis investigated the effectiveness and safety of FNC against the SARS-CoV-2 Omicron...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Xiuping, Yang, Yun, Gong, Baoqiang, Li, Zhiwei, Liang, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586978/
https://www.ncbi.nlm.nih.gov/pubmed/37868850
http://dx.doi.org/10.21037/jtd-23-1093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586978/
https://www.ncbi.nlm.nih.gov/pubmed/37868850
http://dx.doi.org/10.21037/jtd-23-1093

Ejemplares similares